Novel microcarriers consisting of calcium phosphate cement and alginate were prepared for use as three-dimensional scaffolds for the culture and expansion of cells that are effective for bone tissue engineering. The calcium phosphate cement-alginate composite microcarriers were produced by an emulsification of the composite aqueous solutions mixed at varying ratios (calcium phosphate cement powder/alginate solution = 0.8-1.2) in an oil bath and the subsequent in situ hardening of the compositions during spherodization. Moreover, a porous structure could be easily created in the solid microcarriers by soaking the produced microcarriers in water and a subsequent freeze-drying process. Bone mineral-like apatite nanocrystallites were shown to rapidly develop on the calcium phosphate cement-alginate microcarriers under moist conditions due to the conversion of the α-tricalcium phosphate phase in the calcium phosphate cement into a carbonate-hydroxyapatite. Osteoblastic cells cultured on the microspherical scaffolds were proven to be viable, with an active proliferative potential during 14 days of culture, and their osteogenic differentiation was confirmed by the determination of alkaline phosphatase activity. The in situ hardening calcium phosphate cement-alginate microcarriers developed herein may be used as potential three-dimensional scaffolds for cell delivery and tissue engineering of bone.
Novel microcarriers consisting of calcium phosphate cement and alginate were prepared for use as three-dimensional scaffolds for the culture and expansion of cells that are effective for bone tissue engineering. The calcium phosphate cement-alginate composite microcarriers were produced by an emulsification of the composite aqueous solutions mixed at varying ratios (calcium phosphate cement powder/alginate solution = 0.8-1.2) in an oil bath and the subsequent in situ hardening of the compositions during spherodization. Moreover, a porous structure could be easily created in the solid microcarriers by soaking the produced microcarriers in water and a subsequent freeze-drying process. Bone mineral-like apatite nanocrystallites were shown to rapidly develop on the calcium phosphate cement-alginate microcarriers under moist conditions due to the conversion of the α-tricalcium phosphate phase in the calcium phosphate cement into a carbonate-hydroxyapatite. Osteoblastic cells cultured on the microspherical scaffolds were proven to be viable, with an active proliferative potential during 14 days of culture, and their osteogenic differentiation was confirmed by the determination of alkaline phosphatase activity. The in situ hardening calcium phosphate cement-alginate microcarriers developed herein may be used as potential three-dimensional scaffolds for cell delivery and tissue engineering of bone.
Entities:
Keywords:
Microcarriers; alginate; bone regeneration; calcium phosphate cements; cell culture
Spherical particles are gaining increasing interest as the scaffolding matrices for the
culture of tissue cells and for the direct filling of defective bone tissues.[1-3] Particulates with sizes of hundreds of micrometers can provide good
substrate conditions for tissue cells to adhere to and populate on, and further them to
develop into specific tissue forms, consequently healing the defects.[2,3] Biological molecules can also be
incorporated within the spheres to elicit therapeutic efficacy.[4,5] Among the compositions developed, bioactive ceramics have proven to be
potential candidate substrates for bone regeneration. However, those ceramics generally
require high-temperature processing to consolidate and maintain structural integrity, which,
however, is detrimental to the incorporation of bioactive molecules and
therapeutics.[6,7]In contrast, calcium phosphate cements (CPCs) self-set to form hardened materials, and the
compositions are also biocompatible and effective for bone-cell functions.[8,9] We herein used the CPC as the precursor for
the preparation of microspheres. Moreover, alginate was combined with CPC in order to form a
sphere particle more effectively. The CPC and alginate composite system has been
demonstrated to be a useful matrix with its improved mechanical integrity and bone-cell
differentiation.[10,11] The CPC–alginate
microsphere is considered to be properly applied as injectable bone fillers either directly
or with incorporating bioactive therapeutics. Moreover, bone progenitor or stem cells can be
cultivated on the spherical scaffolds for the purpose of bone tissue engineering.While CPC with its in situ hardening property is considered to solidify at room
temperature, the alginate used together with CPC composition can improve the CPC’s setting
ability and, ultimately, the mechanical integrity of the microcarriers.[12] Alginate is a natural
polymer derived from algae, is non-toxic and tissue-compatible, and thus has been widely
used as a biomaterial for wound repair and cell encapsulation.[13] In particular, the CPC–alginate
microcarriers have also been explored to allow the development of macropores within the
structure to retain large spaces for effective culture of tissue cells. The processing route
to prepare CPC–alginate microcarriers is described, and the in vitro bioactive responses are
also addressed for use as bone regeneration materials.
Materials and methods
Preparation and characterization of microcarriers
As the precursor of CPC powder, α-tricalcium phosphate was prepared, as described in a
previous work.[9] In
brief, calculated amounts of calcium carbonate and dicalcium phosphate anhydrous were put
in a platinum crucible and heat-treated at 1400℃ for 5 h and then quenched. About 5%
Na2HPO4, either with or without alginate (Na-alginate, Aldrich),
was used as the liquid phase. The concentration of alginate was 2% or 3%. The CPC powder
and alginate liquid phases were mixed at varying ratios (CPC powder/alginate liquid = 0.8,
0.9, 1.0, 1.1, and 1.2 by weight).Microcarriers of the CPC–alginate were produced by means of a water-in-oil emulsification
method. The CPC–alginate mixture of 1 ml was dropped into a 60-ml oliveoil bath, while
stirring at 380 rpm for about 60 min. The stirring speed was determined to produce
spherical microcarriers with sizes in the hundreds of micrometers range that are
appropriate for cell culture. Furthermore, the stirring time was optimized to enable the
in situ hardening process to form stable microcarriers. After stirring, the microcarriers
were washed with ethanol and lyophilized at −60℃ using a freeze-dryer. In order to provide
a macroporous structure within the spheres, the ethanol-treated spheres were soaked in
distilled water for 1 min and frozen at −20℃ and then lyophilized at −60℃ using a
freeze-dryer.The morphology of the microcarriers was examined with scanning electron microscopy (SEM,
Hitachi S-3000H), and the size of the microcarriers was evaluated from the images. The
microcarriers were soaked in a simulated body fluid (which contains 2.5 mM
Ca2+, 142 mM Na+, 1.5 mM Mg2+, 5.0 mM K+,
125.0 mM Cl−, 27.0 mM HCO3−, 1.0 mM
HPO42−, and 0.5 mM SO42−) for different time
periods to examine any changes in the phase, and the surface morphology was observed using
SEM.[14]
In vitro cell culture on the microcarriers
The biocompatibility of the CPC–alginate microcarriers was briefly examined by the
proliferative potential of the pre-osteoblast cell line (MC3T3-E1).[15] The microcarriers of
30 mg were contained in each well of a 96-well plate, and the cells were seeded at a
density of 5 × 103 cells/well and then cultured in α-minimal essential medium
supplemented with fetal bovine serum containing antibiotics in a humidified atmosphere of
95% CO2 at 37℃.The cell morphology was examined with SEM after fixing the cells with glutaraldehyde
(2.5%), dehydrating with a graded series of ethanol, and treating with
hexamethyldisilazane and gold coating. Cell proliferation was measured by means of the MTS
assay (CellTiter 96 Aqueous One Solution, Promega, USA).[15] For the differentiation study,
osteogenic factors involving 10 mM β-glycerol phosphate and 50 µg/ml
l-ascorbic acid were added to the culture medium. The alkaline
phosphatase activity (ALP), an early osteogenic marker, was determined, as described in
our previous study.[16] Experiments were conducted on three replicate samples. Statistical
analysis was performed using ANOVA. A significant level was considered at p < 0.05.
Results and discussion
The CPC–alginate solutions prepared at different ratios (CPC/alginate = 0.8–1.2) were
demonstrated to be well-developed into a spherical form by the water-in-oil emulsification
method. Figure 1(a) shows the SEM
images of the representative CPC–alginate microcarriers (CPC/alginate = 0.8) at low
magnification. Spherical-shaped particles were well formed, and the surface was shown to
reveal that the CPC particles were several micrometers in size, which were surrounded with
alginate polymeric phase. At high magnification of the representative CPC–alginate
microcarriers (CPC/alginate = 0.8, 1.0, and 1.2), as the powder content (CPC/alginate
ratio) increased, the surface morphology became less dense (Figure 1(b–d)). For all cases, the microcarriers were well-integrated, which is appropriate
for handling in other assays, such as cell tests.
Figure 1.
SEM morphologies of the
CPC/alginate microcarriers. Images were taken at different magnifications
(CPC/alginate ratios of 0.8, 1.0, and 1.2 are marked in each image). Microspherical
particles with hundreds of micrometers in size were well generated at low
magnification (a), and a few micrometer-sized CPC particles and surrounding alginate
are revealed at high magnification (b–d).
SEM morphologies of the
CPC/alginate microcarriers. Images were taken at different magnifications
(CPC/alginate ratios of 0.8, 1.0, and 1.2 are marked in each image). Microspherical
particles with hundreds of micrometers in size were well generated at low
magnification (a), and a few micrometer-sized CPC particles and surrounding alginate
are revealed at high magnification (b–d).The size distributions of the CPC–alginate microcarriers were assessed from the SEM
images and are shown in Figure
2(a). Microcarriers had sizes of about 100–500 µm, and the increase in CPC powder
content increased the microcarrier size (from 183 to 288 µm, on average), as shown in
Figure 2(b). This size range is
considered to be appropriate for the culture of tissue cells upon the spherical substrates
targeting tissue regeneration purposes.[2-4]
Figure
2.
Measurement of sizes of microcarriers with different
CPC/alginate compositions: (a) size distribution and (b) average
size.
Measurement of sizes of microcarriers with different
CPC/alginate compositions: (a) size distribution and (b) average
size.The process of this sphere formation was designed to last for 60 min, which was based on
our previous work on the observation of setting time of CPC (within an hour) for the
powder-to-liquid ratios used herein.[10] Specifically, the self-setting reaction
of the CPC is considered to occur with the alginate solution within the droplets contained
in an oil bath. Because the alginate becomes cross-linked by the exchange with calcium
ions, the alginate should play some role in the hardening of the CPC-based spheres through
reaction with calcium ions released from the CPC composition.[10,11] Therefore, when compared to the pure
CPC, the alginate-added CPC has been shown to have better setting properties, and this
positively affects the resultant mechanical integrity.The obtained CPC–alginate microcarriers exhibited the phase transformation of the initial
CPC composition into a hydroxyapatite (HA) phase, a general reaction in the α-TCP-based
cement under moisture conditions. Figure
3 shows the representative microstructural change of the CPC–alginate
microcarriers during immersion in a fluid for 7 days. Low-magnification image appeared to
show a similar morphological feature to that without immersion (Figure 3(a)). At higher magnification, small
nanocrystallites completely covered the surface of the microcarriers (Figure 3(b)). As shown in the XRD data (Figure 3(c)), the initial α-TCP phase
was transformed into the HA phase after 7 days of immersion. The nanocrystalline HA phase
produced on the CPC–alginate spheres is considered to be favorable for the cell and tissue
responses.
Figure
3.
(a,b) Surface morphological change of microcarriers
(CPC/alginate = 1.0) during immersion in the body simulating medium for 7 days shown
at different magnifications (a,b) and the XRD patterns before and after immersion
for 7 days, showing the development of HA phase, due to the transformation of
α-TCP.
(a,b) Surface morphological change of microcarriers
(CPC/alginate = 1.0) during immersion in the body simulating medium for 7 days shown
at different magnifications (a,b) and the XRD patterns before and after immersion
for 7 days, showing the development of HA phase, due to the transformation of
α-TCP.A feasibility study of the microcarriers was briefly performed by culturing
pre-osteoblastic cells directly on the developed microcarriers. The SEM cell growth images
on the solid microcarriers were taken at different positions and magnifications. Cells
exhibited good adhesion and spreading, with active cytoskeletal processes on the surface
of microcarriers (Figure 4(a)),
and also accumulated at the contact points of microcarriers bridging them together (Figure 4(b) and (c)).
Figure 4.
Cell growth morphology grown on the CPC/alginate
microcarriers during culture for 3 days, taken from SEM.
Cell growth morphology grown on the CPC/alginate
microcarriers during culture for 3 days, taken from SEM.The cell proliferation level, as assessed by the MTS method (Figure 5(a)), showed an ongoing increase in cell
population with time. When grown on the microcarriers, cells were at the same level as the
tissue culture plastic dish, which is used as a positive control. The results suggest that
the developed CPC–alginate microcarriers are cell compatible and would be useful as a
three-dimensional (3D) scaffold for bone regeneration. Furthermore, the effect of the
composite microcarriers on osteogenic differentiation was assessed by means of ALP
activity produced by the cells after culture for 7 and 14 days (Figure 5(b)). At day 7, the ALP level of cells grown
on the microcarriers was comparable to that on the control. After 14 days, the ALP level
on the microcarriers increased substantially, whereas that on the control only slightly
increased. These results confirmed the potential role of the CPC–alginate composite
microcarriers in providing appropriate scaffold conditions for cells to undergo osteogenic
development under the osteogenic medium conditions. It is considered that the transformed
bone-mineral like apatite phase may be an excellent substrate condition for the
osteoblastic differentiation with respect to the culture dish. Moreover, the expected
release of ions may also be possible stimulators of cell differentiation, and more
in-depth studies will be needed as further work.
Figure 5.
(a) Cell proliferation behavior on
the spheres during 14 days, as compared with those on the culture dish control,
showing an ongoing cell growth, and (b) ALP activity of the cells grown on the
microcarriers significantly increased at 14 days, compared to control. (*p < 0.05
by ANOVA for n = 3).
(a) Cell proliferation behavior on
the spheres during 14 days, as compared with those on the culture dish control,
showing an ongoing cell growth, and (b) ALP activity of the cells grown on the
microcarriers significantly increased at 14 days, compared to control. (*p < 0.05
by ANOVA for n = 3).Apart from the compositional merit of the CPC–alginate solid microcarriers, we aimed to
develop the spheres to have a porous structure, which is considered to be effective to
hold tissue cells within the spheres and support their multiplication for tissue
engineering due to their large surface area to volume ratio. The solidified microcarriers
were frozen and lyophilized after being soaked in water. Figure 6 shows the SEM image of the porous
microcarriers. Particulates of a few hundreds of micrometers were obtained after the
lyophilization process; however, the shape was not isotropic, but somewhat irregular. More
noticeable was the formation of a large amount of macropores throughout the spheres, with
pore sizes of 20–50 µm, which also appeared interconnected, as shown in the morphology of
the fragmented sphere. By adopting a simple process, that is, soaking in water followed by
lyophilization, the dense microcarriers could be developed with a porous structure. The
frozen ice crystals were sublimated to leave interconnected pores throughout the spheres.
The size of the pores can be tuned by varying the freezing temperature, i.e., with
increasing temperature, the pore size increases.[17-19] Herein, the developed pore sizes were about 20–50 µm at the freezing
temperature of −20℃. The beneficial effects of the pore structure generated in the
microcarriers are obvious based on previous works that report a high-loading capacity of
cells for use as tissue engineering scaffold.[2,6,20,21] Further work is needed regarding the
applications of this porous microcarrier.
Figure 6.
SEM images at different magnifications, showing
the morphology of the porous-structured CPC/alginate microcarriers produced by
immersing the solidified CPC/alginate spheres in water, followed by freeze-drying to
create the pores.
SEM images at different magnifications, showing
the morphology of the porous-structured CPC/alginate microcarriers produced by
immersing the solidified CPC/alginate spheres in water, followed by freeze-drying to
create the pores.
Conclusions
CPC–alginate microcarriers were newly developed as a 3D matrix for bone repair. The
self-setting reaction of the composition facilitated ease-of-sphere formation at mild
conditions. The resultant bone-mineral-like apatite phase transformed from the initial CPC
powder is considered to provide excellent substrate conditions for bone-associated cells.
Preliminary cellular study proved that the spheres were favorable for cells to adhere,
spread, and proliferate on, and to undergo osteogenic differentiation. Taken together, the
newly developed CPC–alginate microcarriers are considered to be useful as a 3D matrix for
bone regeneration.
Authors: Nasim Annabi; Jason W Nichol; Xia Zhong; Chengdong Ji; Sandeep Koshy; Ali Khademhosseini; Fariba Dehghani Journal: Tissue Eng Part B Rev Date: 2010-08 Impact factor: 6.389
Authors: Tobias J Brunner; Marc Bohner; Claudio Dora; Christian Gerber; Wendelin J Stark Journal: J Biomed Mater Res B Appl Biomater Date: 2007-11 Impact factor: 3.368
Authors: Gengtao Qiu; Hansen Wu; Mingguang Huang; Tao Ma; Abraham Schneider; Thomas W Oates; Michael D Weir; Hockin H K Xu; Liang Zhao Journal: Mater Sci Eng C Mater Biol Appl Date: 2021-07-10
Authors: George Gonçalves Dos Santos; Luisa Queiroz Vasconcelos; Suelen Cristina da Silva Poy; Renata Dos Santos Almeida; Aryon de Almeida Barbosa Júnior; Silvia Rachel de Albuquerque Santos; Alexandre Malta Rossi; Fúlvio Borges Miguel; Fabiana Paim Rosa Journal: Acta Cir Bras Date: 2019-02-28 Impact factor: 1.388